We assessed Calcofluor white staining, Aspergillus polymerase chain reaction, and a galactomannan enzyme immunoassay for diagnosis of fungal infection with use of computed tomography-guided percutaneous lung biopsy specimens obtained from 61 patients. The sensitivity and specificity of computerized tomography, Aspergillus polymerase chain reaction, and galactomannan enzyme immunoassay were 100% and 50%, 100% and 86%, and 88% and 94%, respectively.Invasive aspergillosis (IA) is a major cause of morbidity and mortality among immunosuppressed patients. Case-fatality rates range from 30% to 80% among neutropenic patients, and death results, at least in part, from difficulties in obtaining a reliable diagnosis in the early stage of disease [1]. No method has proven to be sufficiently sensitive and specific to allow adequate diagnosis.The use of CT allows diagnosis early in the course of pulmonary IA and helps to improve the overall survival rate among febrile, neutropenic patients [2]. Previous studies reported that the CT finding of a halo sign is indicative of pulmonary aspergillosis in neutropenic patients [3]. Thus far, it is impossible to distinguish Aspergillus species from other fungi on the basis of clinical signs [4]. However, identification of the causative organisms is highly warranted in the clinical context to deter- mine adequate therapy. Zygomycetes have in vivo and in vitro resistance to the newer antifungals, such as voriconazole and caspofungin [5]. The number of infections due to zygomycetes have increased in our hospital and in other health care centers, indicating the need for a powerful means of diagnosis [6].We evaluated the utility of Calcofluor white staining (CFWS), galactomannan EIA (GM EIA), and Aspergillus PCR of CTguided lung biopsy specimens for diagnosis of rapidly invasive fungal infection in immunosuppressed patients.Methods. A prospective study conducted from October 2003 through September 2006 evaluated 61 patients who had hematologic malignancies (46 patients) or who had undergone solid-organ transplantation (15 patients) and who had CT findings highly suggestive of an invasive fungal infection. The specimens were obtained by CT-guided percutaneous biopsy and were investigated for the presence of fungal elements. All CTguided percutaneous biopsies were performed with an automated biopsy gun that contained a detachable coaxial cutting needle system, as described by Lucidarme et al. [7]. In our study, an outer coaxial needle with a 17-gauge diameter and an inner biopsy needle with an 18-gauge diameter were chosen. Interventions were performed only for patients with platelet counts of 50,000 platelets/mL and with prothrombin and partial thromboplastin times within the normal limits. Lesions that had a diameter 11 cm and that were most easily assessable were chosen for biopsy.Biopsy specimens were transferred to 2 mL of NaCl, minced, and homogenized aseptically. Samples were then vortexed, stored at room temperature for 30 min, and centrifuged. Supernatants and homogenized tissues wer...
Pancreatic cancer is one of the most devastating human malignancies. Despite considerable research efforts, it remains resistant to almost all available treatment regimens. The human trophoblast cell-surface antigen, TROP2, was found to be strongly expressed in a variety of human epithelial cancers, correlating with aggressiveness and poor prognosis. TROP2 antigen expression was investigated retrospectively by immunohistochemistry in paraffin-embedded primary tumour tissue samples from a series (n ¼ 197) of consecutive patients with pancreatic adenocarcinoma. Survival was calculated using Kaplan -Meier curves. Parameters found to be of prognostic significance in univariate analysis were verified in a multivariate Cox regression model. TROP2 overexpression was observed in 109 (55%) of 197 pancreatic cancer patients and was significantly associated with decreased overall survival (Po0.01). By univariate analysis, TROP2 overexpression was found to correlate with the presence of lymph node metastasis (P ¼ 0.04) and tumour grade (P ¼ 0.01). Furthermore, in the subgroup of patients treated surgically with curative intent, TROP2 overexpression significantly correlated with poor progression-free survival (Po0.01). Multivariate analyses revealed TROP2 to be an independent prognosticator. These findings suggest for the first time that TROP2 could be a novel prognostic biomarker for pancreatic cancer. Targeting TROP2 might be a useful treatment approach for patients with pancreatic cancer overexpressing this cell-surface marker.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.